Immune recall improves antibody durability and breadth to SARS-CoV-2 variants.

In general, the Pfizer–BioNTech vaccine induced slightly lower anti-S and anti-RBD IgG than the Moderna vaccine, but the difference did not reach statistical significance in these cohorts (Fig.

also in 111,027 other papers